Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metyrapone in Mild Autonomous Cortisol Secretion (MACS)
NCT07138274Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Oct 2026
- Primary completion
- Jun 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metyrapone in Autonomous Cortisol Secretion (ACS), sponsored by Mayo Clinic. Started Oct 2026; status: recruiting.
02
Drugs
metyrapone
03
Conditions
Autonomous Cortisol Secretion (ACS)
Beyond the preview
Go deeper on NCT07138274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07138274.